>
Switch to:

Maccura Biotechnology Co Gross Margin %

: 55.47% (As of Jun. 2021)
View and export this data going back to 2015. Start your Free Trial

Gross Margin % is calculated as gross profit divided by its revenue. Maccura Biotechnology Co's Gross Profit for the three months ended in Jun. 2021 was CN¥494 Mil. Maccura Biotechnology Co's Revenue for the three months ended in Jun. 2021 was CN¥891 Mil. Therefore, Maccura Biotechnology Co's Gross Margin % for the quarter that ended in Jun. 2021 was 55.47%.

Warning Sign:

Maccura Biotechnology Co Ltd gross margin has been in long term decline. The average rate of decline per year is -1.5%.


The historical rank and industry rank for Maccura Biotechnology Co's Gross Margin % or its related term are showing as below:

SZSE:300463' s Gross Margin % Range Over the Past 10 Years
Min: 51.8   Med: 53.93   Max: 59.25
Current: 55.71

51.8
59.25

During the past 10 years, the highest Gross Margin % of Maccura Biotechnology Co was 59.25%. The lowest was 51.80%. And the median was 53.93%.

SZSE:300463's Gross Margin % is ranked higher than
66% of the 101 Companies
in the Medical Diagnostics & Research industry.

( Industry Median: 46.98 vs. SZSE:300463: 55.71 )

Maccura Biotechnology Co had a gross margin of 55.47% for the quarter that ended in Jun. 2021 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Maccura Biotechnology Co was -1.50% per year.


Maccura Biotechnology Co Gross Margin % Historical Data

The historical data trend for Maccura Biotechnology Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maccura Biotechnology Co Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Gross Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.10 53.75 51.80 51.82 53.12

Maccura Biotechnology Co Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Gross Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.65 54.78 52.59 60.28 55.47

Competitive Comparison

For the Diagnostics & Research subindustry, Maccura Biotechnology Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Maccura Biotechnology Co Gross Margin % Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Maccura Biotechnology Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Maccura Biotechnology Co's Gross Margin % falls into.



Maccura Biotechnology Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Maccura Biotechnology Co's Gross Margin for the fiscal year that ended in Dec. 2020 is calculated as

Gross Margin % (A: Dec. 2020 )=Gross Profit (A: Dec. 2020 ) / Revenue (A: Dec. 2020 )
=1967.5 / 3703.877
=(Revenue - Cost of Goods Sold) / Revenue
=(3703.877 - 1736.392) / 3703.877
=53.12 %

Maccura Biotechnology Co's Gross Margin for the quarter that ended in Jun. 2021 is calculated as


Gross Margin % (Q: Jun. 2021 )=Gross Profit (Q: Jun. 2021 ) / Revenue (Q: Jun. 2021 )
=494.2 / 890.837
=(Revenue - Cost of Goods Sold) / Revenue
=(890.837 - 396.655) / 890.837
=55.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Maccura Biotechnology Co  (SZSE:300463) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Maccura Biotechnology Co had a gross margin of 55.47% for the quarter that ended in Jun. 2021 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Maccura Biotechnology Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of Maccura Biotechnology Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Maccura Biotechnology Co Business Description

Maccura Biotechnology Co logo
Traded in Other Exchanges
N/A
Address
Number 8, 2nd Anhe Road, Hi-tech Zone, Chengdu, CHN, 611731
Maccura Biotechnology Co Ltd is a China-based in-vitro diagnostic (IVD) integration company engaged in the research and development, production and sales of IVD products. It is also engaged in the sales of foreign brands of in vitro diagnostic products as an agent. The company's developed product and technology development platforms cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.

Maccura Biotechnology Co Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)